FDA-Drug2026-09-23Class IICHEMICAL
Inventia Healthcare chlorthalidone tablets recalled for failed dissolution specifications
What this means
Inventia Healthcare Limited's chlorthalidone 25 mg tablets (batch RISA24002, expiring 04/2027) failed to meet dissolution specifications, meaning the tablets may not break down properly in the body. This could affect how well the medication works. About 13,567 bottles were distributed nationwide.
- Check if you have chlorthalidone from Inventia Healthcare with batch number RISA24002
- Contact your pharmacy or doctor if you have this medication
- Do not stop taking your blood pressure medication without talking to your doctor first
The agency's original wording
Hazard
Failed Dissolution Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S. Nationwide
Affected count
13567 bottles
Manufactured in
Additional Ambernath Midc, Ambernath East; F1-F1/1-F75/1, Kalyan, N/A, India
Products
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0852-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.